Breakthrough With a Cost: Navigating Tepezza’s Auditory Complications
Tepezza, an FDA-approved medication, has provided optimism for individuals affected by thyroid eye disease (TED). As reported by eMPR.com, the drug was first approved by the U.S. Food and Drug Administration in January 2020. Since then, the drug has gained significant popularity as a treatment …